Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Connective Tissue Cell Types

Connective Tissue Cell Types

Connective tissue develops from the mesoderm of a developing embryo and consists of cells, fibers, and ground substance: a gel-like material containing large complexes of carbohydrates and proteins. Connective tissue was first identified as a separate tissue family in the 18th century, and Johannes Peter Muller coined the term connective tissue.
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Implantable living materials autonomously deliver therapeutics using contained engineered bacteria.

Science (New York, N.Y.)·2026

Same author

Feeder-free generation of functional dendritic cells from human pluripotent stem cells.

Journal for immunotherapy of cancer·2026

Same author

Matrix Viscoelasticity Regulates Dendritic Cell Migration and Immune Priming.

Advanced materials (Deerfield Beach, Fla.)·2026

Same author

Hemostatic Tough Adhesives seal tissue and control hemorrhage.

Nature communications·2026

Same author

Marine-Derived Medical Devices and Therapeutic Delivery Systems.

Advanced healthcare materials·2026

Same author

Mechanical performance of hybrid polymer-lipid vesicles with leaflet asymmetry engineered using microfluidics.

Proceedings of the National Academy of Sciences of the United States of America·2026

Same journal

Erratum for the Research Article "Guanosine diphosphate-mannose suppresses homologous recombination repair and potentiates antitumor immunity in triple-negative breast cancer".

Science translational medicine·2026

Same journal

CAR T cell therapy selectively depletes disease-driving mutant calreticulin cells in xenotransplants and human organoid models of myelofibrosis.

Science translational medicine·2026

Same journal

Bioresponsive microneedle stent provides anastomosis and postoperative adjuvant therapy in preclinical resectable intestinal diseases.

Science translational medicine·2026

Same journal

Alzheimer's disease proteome-wide association study implicates adaptive immunity and identifies risk genes LILRB1 and SIRPA.

Science translational medicine·2026

Same journal

KSHV-infected endothelial cells expand and up-regulate angiogenic pathways and CXCR4 in patient-derived Kaposi sarcoma models.

Science translational medicine·2026

Same journal

Hypoxia-driven T cell-macrophage-stromal cross-talk sustains fibrosis in preclinical models of cutaneous chronic graft-versus-host disease.

Science translational medicine·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Aug 29, 2025

Author Spotlight: Advancements in Cell and Tissue Engineering for Tendon Repair

Author Spotlight: Advancements in Cell and Tissue Engineering for Tendon Repair

Published on: March 1, 2024

Advances toward transformative therapies for tendon diseases.

Benjamin R Freedman^1,2, David J Mooney^1,2, Eckhard Weber³

¹John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138, USA.

Science Translational Medicine

|September 7, 2022

Summary

This summary is machine-generated.

Current tendon disease treatments focus on symptom relief. This review explores novel drugs, biologics, and biomaterials for disease modification, aiming for transformative therapies through deeper understanding and collaboration.

More Related Videos

Author Spotlight: Advancing Tendon Research by Developing Mouse Assembloids to Understand Cellular Mechanisms

Author Spotlight: Advancing Tendon Research by Developing Mouse Assembloids to Understand Cellular Mechanisms

Published on: March 22, 2024

Applying a Three-dimensional Uniaxial Mechanical Stimulation Bioreactor System to Induce Tenogenic Differentiation of Tendon-Derived Stem Cells

Applying a Three-dimensional Uniaxial Mechanical Stimulation Bioreactor System to Induce Tenogenic Differentiation of Tendon-Derived Stem Cells

Published on: August 1, 2020

Related Experiment Videos

Last Updated: Aug 29, 2025

Author Spotlight: Advancements in Cell and Tissue Engineering for Tendon Repair

Author Spotlight: Advancements in Cell and Tissue Engineering for Tendon Repair

Published on: March 1, 2024

Author Spotlight: Advancing Tendon Research by Developing Mouse Assembloids to Understand Cellular Mechanisms

Author Spotlight: Advancing Tendon Research by Developing Mouse Assembloids to Understand Cellular Mechanisms

Published on: March 22, 2024

Applying a Three-dimensional Uniaxial Mechanical Stimulation Bioreactor System to Induce Tenogenic Differentiation of Tendon-Derived Stem Cells

Applying a Three-dimensional Uniaxial Mechanical Stimulation Bioreactor System to Induce Tenogenic Differentiation of Tendon-Derived Stem Cells

Published on: August 1, 2020

Area of Science:

Orthopedics
Regenerative Medicine
Biomaterials Science

Background:

Approved therapies for tendon diseases primarily offer symptomatic pain relief and physiotherapy.
Existing treatments have not significantly altered clinical practice for tendon disease management.

Purpose of the Study:

To review recent advances in novel drug, biologic, and biomaterial therapies for tendon diseases.
To discuss perspectives for translating integrated therapeutic approaches.
To highlight the shift towards disease modification and prevention.

Main Methods:

Comprehensive literature review of current research in tendon disease therapeutics.
Analysis of emerging drug, biologic, and biomaterial development.
Exploration of clinical, cellular, and molecular pathology insights.

Main Results:

Novel drugs, biologic products, and biomaterial therapies show promise for tendon disease treatment.
A shift from symptomatic relief to disease modification is a key trend.
Optimization of therapeutic delivery and interdisciplinary collaboration are crucial.

Conclusions:

Transformative therapies for tendon diseases require a move beyond symptom management.
Integrated approaches combining novel agents and optimized delivery are needed.
Enhanced understanding of pathology and collaborative platforms will accelerate translation.